Matt OBrien
Stock Analyst at Piper Sandler
(2.86)
# 1,507
Out of 5,182 analysts
8
Total ratings
87.5%
Success rate
39.21%
Average return
Main Sectors:
Stocks Rated by Matt OBrien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HTFL HeartFlow | Initiates: Overweight | $38 | $31.73 | +19.76% | 1 | Sep 2, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $55 → $62 | $67.43 | -8.05% | 6 | Oct 29, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $70 → $90 | $19.82 | +354.09% | 1 | Feb 25, 2020 |
HeartFlow
Sep 2, 2025
Initiates: Overweight
Price Target: $38
Current: $31.73
Upside: +19.76%
Merit Medical Systems
Oct 29, 2020
Maintains: Overweight
Price Target: $55 → $62
Current: $67.43
Upside: -8.05%
Tandem Diabetes Care
Feb 25, 2020
Maintains: Overweight
Price Target: $70 → $90
Current: $19.82
Upside: +354.09%